Grafa News and Videos — Page 513

The Greens demand a ban on SMSF residential property borrowing in exchange for a crucial federal budget vote in the Senate.

Arrowhead Pharmaceuticals (NASDAQ:ARWR) announced today that the European Commission has granted marketing authorization for REDEMPLO (plozasiran) as an adjunct to diet for treating adults with familial chylomicronemia syndrome (FCS).

HII (NYSE:HII) announced today that its Mission Technologies division has received a $418 million, five-year indefinite delivery/indefinite quantity (IDIQ) contract to support U.S. Navy fleet operational readiness.

Eli Lilly (NYSE:LLY) announced that its board of directors has declared a cash dividend of $1.73 per share on outstanding common stock for the third quarter of 2026.

SpaceX (NASDAQ:SPCX) has initiated its first-ever bond sale to repay outstanding debt following a 7% decline in its share price during early Monday trade.

INVO Fertility (NASDAQ:IVF) recorded a 23% increase in year-over-year revenue to $2.02 million for the first quarter of 2026.

NRx Pharmaceuticals (NASDAQ:NRXP) secured FDA authorization for a depression treatment protocol with an initial drug cost of $0.

TScan Therapeutics (NASDAQ:TCRX) reported initial clinical trial data showing 11 out of 14 blood cancer patients achieved complete donor chimerism.

Eledon Pharmaceuticals (NASDAQ:ELDN) reported extension data showing a 12 mL/min kidney function advantage at 18 months.

Clinical-stage biopharmaceutical firm Traws Pharma (NASDAQ:TRAW) updated guidance for its influenza prophylaxis program to enable a planned Phase 2a trial.